<?xml version='1.0' encoding='utf-8'?>
<document id="21264108"><sentence text="A study on drug-drug interaction of esomeprazole and anti-diabetic drugs."><entity charOffset="36-48" id="DDI-PubMed.21264108.s1.e0" text="esomeprazole" /></sentence><sentence text="Drug-drug interaction between esomeprazole at therapeutic and higher doses and sulfonylureas was studied"><entity charOffset="30-42" id="DDI-PubMed.21264108.s2.e0" text="esomeprazole" /><entity charOffset="79-92" id="DDI-PubMed.21264108.s2.e1" text="sulfonylureas" /><pair ddi="false" e1="DDI-PubMed.21264108.s2.e0" e2="DDI-PubMed.21264108.s2.e0" /><pair ddi="false" e1="DDI-PubMed.21264108.s2.e0" e2="DDI-PubMed.21264108.s2.e1" /></sentence><sentence text=" Sulfonylureas (tolbutamide 40 mg/kg and glibenclamide 40 Âµg/kg) were administered and the time to onset of hypoglycemia, the duration of the hypoglycemia, and the peak hypoglycemia were determined"><entity charOffset="1-14" id="DDI-PubMed.21264108.s3.e0" text="Sulfonylureas" /><entity charOffset="16-27" id="DDI-PubMed.21264108.s3.e1" text="tolbutamide" /><entity charOffset="41-54" id="DDI-PubMed.21264108.s3.e2" text="glibenclamide" /><pair ddi="false" e1="DDI-PubMed.21264108.s3.e0" e2="DDI-PubMed.21264108.s3.e0" /><pair ddi="false" e1="DDI-PubMed.21264108.s3.e0" e2="DDI-PubMed.21264108.s3.e1" /><pair ddi="false" e1="DDI-PubMed.21264108.s3.e0" e2="DDI-PubMed.21264108.s3.e2" /><pair ddi="false" e1="DDI-PubMed.21264108.s3.e1" e2="DDI-PubMed.21264108.s3.e1" /><pair ddi="false" e1="DDI-PubMed.21264108.s3.e1" e2="DDI-PubMed.21264108.s3.e2" /></sentence><sentence text=" Esomeprazole (1"><entity charOffset="1-13" id="DDI-PubMed.21264108.s4.e0" text="Esomeprazole" /></sentence><sentence text="8 mg/kg, 3" /><sentence text="6 mg/kg, and 30 mg/kg) was administered for 8 days and its influence on sulfonylurea-induced hypoglycemia was studied"><entity charOffset="72-84" id="DDI-PubMed.21264108.s6.e0" text="sulfonylurea" /></sentence><sentence text=" Therapeutic doses of esomeprazole, i"><entity charOffset="22-34" id="DDI-PubMed.21264108.s7.e0" text="esomeprazole" /></sentence><sentence text="e" /><sentence text=", 1" /><sentence text="8 mg/kg and 3" /><sentence text="6 mg/kg dose did not influence the hypoglycemia induced by sulfonylureas"><entity charOffset="59-72" id="DDI-PubMed.21264108.s11.e0" text="sulfonylureas" /></sentence><sentence text=" However, a higher dose, i" /><sentence text="e" /><sentence text=", 30 mg/kg, did significantly enhance the duration of hypoglycemia and the peak hypolgycemia" /><sentence text=" Esomeprazole (30 mg/kg) by itself did not reduce the blood glucose levels; therefore, a pharmacodynamic type of drug interaction can be ruled out"><entity charOffset="1-13" id="DDI-PubMed.21264108.s15.e0" text="Esomeprazole" /><entity charOffset="60-67" id="DDI-PubMed.21264108.s15.e1" text="glucose" /><pair ddi="false" e1="DDI-PubMed.21264108.s15.e0" e2="DDI-PubMed.21264108.s15.e0" /><pair ddi="false" e1="DDI-PubMed.21264108.s15.e0" e2="DDI-PubMed.21264108.s15.e1" /></sentence><sentence text=" Similarly, a pharmacokinetic type of drug interaction may be ruled out at therapeutic doses" /><sentence text=" The CYP isoenzyme system involved in the metabolism of sulfonylureas are not very sensitive to esomeprazole and the dose and frequency of administration of sulfonylurea need not be readjusted when they are used concomitantly with esomeprazole (at therapeutic doses)"><entity charOffset="56-69" id="DDI-PubMed.21264108.s17.e0" text="sulfonylureas" /><entity charOffset="96-108" id="DDI-PubMed.21264108.s17.e1" text="esomeprazole" /><entity charOffset="157-169" id="DDI-PubMed.21264108.s17.e2" text="sulfonylurea" /><entity charOffset="231-243" id="DDI-PubMed.21264108.s17.e3" text="esomeprazole" /><pair ddi="false" e1="DDI-PubMed.21264108.s17.e0" e2="DDI-PubMed.21264108.s17.e0" /><pair ddi="false" e1="DDI-PubMed.21264108.s17.e0" e2="DDI-PubMed.21264108.s17.e1" /><pair ddi="false" e1="DDI-PubMed.21264108.s17.e0" e2="DDI-PubMed.21264108.s17.e2" /><pair ddi="false" e1="DDI-PubMed.21264108.s17.e0" e2="DDI-PubMed.21264108.s17.e3" /><pair ddi="false" e1="DDI-PubMed.21264108.s17.e1" e2="DDI-PubMed.21264108.s17.e1" /><pair ddi="false" e1="DDI-PubMed.21264108.s17.e1" e2="DDI-PubMed.21264108.s17.e2" /><pair ddi="false" e1="DDI-PubMed.21264108.s17.e1" e2="DDI-PubMed.21264108.s17.e3" /><pair ddi="false" e1="DDI-PubMed.21264108.s17.e2" e2="DDI-PubMed.21264108.s17.e2" /><pair ddi="false" e1="DDI-PubMed.21264108.s17.e2" e2="DDI-PubMed.21264108.s17.e3" /></sentence><sentence text="" /></document>